PatientMatch — Privacy-first clinical trial discovery

42 trials

Pancreatic AdenocarcinomaRecruiting now

Enrolling now24

Nationwide

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Clasp Therapeutics, Inc.

Ph 1·~3yr·21 sites in AZ, CA, FL +10

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Astellas Pharma Global Development, Inc.

Ph 3·12 sites in CA, FL, KY +5

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Physical Activity and Survival in Advanced Cancer

M.D. Anderson Cancer Center

Device·~16yr·1 site in TX

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

UNC Lineberger Comprehensive Cancer Center

Ph 1/2·~3yr·1 site in NC

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

Gemcitabine and Nab-Paclitaxel Infusion Schedule for Metastatic Pancreatic Cancer

Anne Noonan

Ph 2·~6yr·1 site in OH

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

Medical University of South Carolina

Ph 2·~4yr·1 site in SC

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

iExosomes for Pancreatic Cancer

M.D. Anderson Cancer Center

Ph 1/2·~6yr·1 site in TX

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

Immunotherapy and Irreversible Electroporation for Advanced Pancreatic Cancer

University of Louisville

Procedure·Ph 2·~12yr·1 site in KY

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Mayo Clinic

Ph 1/2·~4yr·1 site in FL

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

University of Chicago

Ph 1·~7yr·1 site in IL

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Revolution Medicines, Inc.

Ph 3·2 sites in NV, OH

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Revolution Medicines, Inc.

Ph 1·~3yr·5 sites in MI, TX, VA

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Ph 1/2·~5yr·3 sites in MI, TX, UT

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Diakonos Oncology Corporation

Ph 1·~7yr·3 sites in TX

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Ph 1/2·~7yr·11 sites in CA, IA, NJ +4

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study of NT-175 in Adults With Advanced Solid Tumors

AstraZeneca

Ph 1·~16yr·18 sites in AZ, CA, FL +9

Enrolling now

16q~4min

Check if I qualify View study

Nationwide

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Seagen, a wholly owned subsidiary of Pfizer

Ph 1·~5yr·25 sites in AL, CA, IA +5

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

High Volume Washing of the Abdomen After Surgery for Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Procedure·~10yr·2 sites in OH, PA

Enrolling now

5q~2min

Check if I qualify View study

Nationwide

Prehabilitation for Cancer Surgery

Case Comprehensive Cancer Center

Ph 1/2·~6mo·1 site in OH

Enrolling now

4q~2min

Check if I qualify View study

Nationwide

A Phase 1 Trial of OKN4395 and Pembrolizumab

Epkin

Ph 1·~4yr·3 sites in CA, TX

Enrolling now

21q~5min

Check if I qualify View study

Nationwide

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Ashish Manne

Device·Ph 2·~4yr·1 site in OH

Enrolling now

17q~4min

Check if I qualify View study

Nationwide

Alpha Radiation Emitters Device for Pancreatic Cancer Treatment

Alpha Tau Medical LTD.

Device·~1.5yr·13 sites in AZ, CA, FL +3

Enrolling now

21q~5min

Check if I qualify View study

Nationwide

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Baylor College of Medicine

Ph 1·~18yr·1 site in TX

Enrolling now

18q~5min

Check if I qualify View study

Nationwide

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

Baylor Research Institute

Ph 2·~6yr·1 site in TX

Enrolling now

19q~5min

Check if I qualify View study